Article
Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA - 1 Oct 2014
Simpson C A, Foer D, Lee G S, Bihuniak J, Sun B, Sullivan R, Belsky J, Insogna K L
Abstract excerpt
SUMMARY: We compared circulating levels of Wnt inhibitors among patients with high bone mass mutations in LRP5, unaffected kindred, and unrelated normal controls. Inhibitors were unchanged in affected and unaffected kindred. We saw no meaningful differences between controls and affected individua...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
